Rezultati
eNauka >
Rezultati >
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry
| Naziv: | Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry | Autori  : | Lund, Lars H.; ...; Zdravković, Marija   ; ...; Seferović, Petar M. ; ...; (broj koautora 30) |
Godina: | 2024 | Publikacija: | European journal of heart failure | ISSN: | 1388-9842 European Journal of Heart Failure Pretraži identifikator |
Izdavač: | Chichester : Wiley | Tip rezultata: | Naučni članak | Kolacija: | vol. 26 br. 12 str. 2487-2501 | DOI: | 10.1002/ejhf.3445 | WoS-ID: | 001309897800001 | Scopus-ID: | 2-s2.0-85203671881 | PMID: | 39257278 | URI: | https://enauka.gov.rs/handle/123456789/935101 | URL: | https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3445 | Projekat: | EORP Abbott Vascular Int. Amgen Cardiovascular AstraZeneca AB Bayer AG Boehringer Ingelheim Bristol Myers Squibb Daichii Sankyo Europe GmbH Edwards Lifesciences Novartis Pharma Servier Vifor |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.